2005
DOI: 10.1016/s1098-3015(10)67383-4
|View full text |Cite
|
Sign up to set email alerts
|

Puk6 Economic Impact of Extended-Release Tolterodine Versus Immediate-and Extended-Release Oxybutynin Among Commercially-Insured Persons With Overactive Bladder

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles